Clinical Trial Update: ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adenosine after pulmonary vein isolation to target dormant conduction in paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Paroxysmal Atrial Fibrillation, Pulmonary Vein Isolation | Phase 4 | Status: COMPLETED